Comparison of the therapeutic effects recombinant human acidic and basic fibroblast growth factors in wound healing in diabetic patients

Journal of Health Science

Volumn 54, Issue 4, 2008, Pages 432-440

  Tan, Yi ^a,b   Xiao, Jian ^a   Huang, Zhifeng ^a   Xiao, Yechen ^c   Lin, Shaoqiang ^a   Jin, Litai ^a   Feng, Wenke ^a,b   Cai, Lu ^a,b   Li, Xiaokun ^a,b,d  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

^c JILIN AGRICULTURAL UNIVERSITY   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

Acidic fibroblast growth factor; Clinical observation; Diabetic wound healing

Indexed keywords

IODINE 125; RECOMBINANT ACIDIC FIBROBLAST GROWTH FACTOR; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG TISSUE LEVEL; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; TIME TO MAXIMUM PLASMA CONCENTRATION; WOUND HEALING; WOUND HEALING IMPAIRMENT;

BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS;

EID: 48749090758     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.54.432     Document Type: Article

References (36)

1. Blakytny, R. and Jude, E. (2006) The molecular biology of chronic wounds and delayed healing in diabetes. Diabet. Med., 23, 594-608.
2. Blakytny, R., Jude, E. B., Martin Gibson, J., Boulton, A. J. and Ferguson, M. W. (2000) Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers. J. Pathol., 190, 589-594.
3. Jude, E. B., Blakytny, R., Bulmer, J., Boulton, A. J. and Ferguson, M. W. (2002) Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet. Med., 19, 440-447.
4. Brem, H. and Tomic-Canic, M. (2007) Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest., 117, 1219-1222.
5. Inoue, M., Ono, I., Tateshita, T., Kuroyanagi, Y. and Shioya, N. (1998) Effect of a collagen matrix containing epidermal growth factor on wound contraction. Wound Repair Regen., 6, 213-222.
6. Lee, A. R. (2005) Enhancing dermal matrix regeneration and biomechanical properties of 2nd degree-burn wounds by EGF-impregnated collagen sponge dressing. Arch. Pharm. Res., 28, 1311-1316.
7. Cheng, B., Liu, H. W., Fu, X. B., Sun, T. Z. and Sheng, Z. Y. (2007) Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats. J. Dermatol. Sci., 45, 193-201.
8. Gerwins, P., Skoldenberg, E. and Claesson-Welsh, L. (2000) Function of fibroblast growth factors and vascular endothelial growth factors and their receptors in angiogenesis. Crit. Rev. Oncol. Hematol., 34, 185-194.
9. Li, S. H., Cai, S. X., Liu, B., Ma, K. W., Wang, Z. P. and Li, X. K. (2006) In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor. Acta Pharmacol. Sin., 27, 754-759.
10. Huang, Z., Zheng, Q., Wu, X., Su, Z., Xu, H., Tan, Y., Feng, W., Li, X. and Cai, L. (2007) Enhanced protection of modified human acidic fibroblast growth factor with polyethylene glycol against ischemia/reperfusion-induced retinal damage in rats. Toxicol. Lett., 170, 146-156.
11. Li, X. K., Lin, Z. F., Li, Y., Hu, S., Tan, Y., Huang, Z., Meng, J., Liang, L. M., Xiao, J., Qu, J. and Cai, L. (2007) Cardiovascular protection of nonmitogenic human acidic fibroblast growth factor from oxidative damage in vitro and in vivo. Cardiovasc. Pathol., 16, 85-91.
12. Fu, X., Yang, Y., Li, X., Sun, T., Wang, Y. and Sheng, Z. (1998) Ischemia and reperfusion impair the gene expression of endogenous basic fibroblast growth factor (bFGF) in rat skeletal muscles. J. Surg. Res., 80, 88-93.
13. Richard, J. L., Parer-Richard, C., Daures, J. P., Clouet, S., Vannereau, D., Bringer, J., Rodier, M., Jacob, C. and Comte-Bardonnet, M. (1995) Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care, 18, 64-69.
14. Grazul-Bilska, A. T., Luthra, G., Reynolds, L. P., Bilski, J. J., Johnson, M. L., Adbullah, S. A., Redmer, D. A. and Abdullah, K. M. (2002) Effects of basic fibroblast growth factor (FGF-2) on proliferation of human skin fibroblasts in type II diabetes mellitus. Exp. Clin. Endocrinol. Diabetes, 110, 176-181.
15. Asai, J., Takenaka, H., Ichihashi, K., Ueda, E., Katoh, N. and Kishimoto, S. (2006) Successful treatment of diabetic gangrene with topical application of a mixture of peripheral blood mononuclear cells and basic fibroblast growth factor. J. Dermatol., 33, 349-352.
16. Nakada, T., Saito, Y., Chikenji, M., Koda, S., Higuchi, M., Kawata, K., Ishida, S., Takahashi, S., Kondo, S., Kubota, Y., Kubota, I. and Shimizu, Y. (2006) Therapeutic outcome of hyperbaric oxygen and basic fibroblast growth factor on intractable skin ulcer in legs: preliminary report. Plast. Reconstr. Surg., 117, 646-651.
17. Matuszewska, B., Keogan, M., Fisher, D. M., Soper, K. A., Hoe, C. M., Huber, A. C. and Bondi, J. V. (1994) Acidic fibroblast growth factor: evaluation of topical formulations in a diabetic mouse wound healing model. Pharm. Res., 11, 65-71.
18. Mellin, T. N., Cashen, D. E., Ronan, J. J., Murphy, B. S., DiSalvo, J. and Thomas, K. A. (1995) Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice. J. Invest. Dermatol., 104, 850-855.
19. Li, X. K., Wu, W. X. K. and Zheng, Q. (2001) Construction of high-level expression strain of human acidic fibroblast growth Factor. Journal of South China University of Technology, 29, 61-64.
20. Weng, L. X., Fu, X. B., Li, X. X., Sun, T. Z., Zheng, S. Y., Chen, W. and Li, J. Y. (2005) Protective effects of acidic fibroblast growth factor on intestinal ischemia/reperfusion in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 17, 98-101.
21. Ma, B., Cheng, D. S., Xia, Z. F., Ben, D. F., Lu, W., Cao, Z. F., Wang, Q., He, J., Chai, J. K., Shen, C. A., Sun, Y. H., Zhang, G. A. and Hu, X. H. (2007) Randomized, multicenter, double-blind, and placebo-controlled trial using topical recombinant human acidic fibroblast growth factor for deep partial-thickness burns and skin graft donor site. Wound Repair Regen., 15, 795-799.
22. Vigorito, E., Robles, A., Balter, H., Nappa, A. and Goni, F. (1995) [125I]IgM (KAU) human monoclonal cold agglutinin: labelling and studies on its biological activity. Appl. Radiat. Isot., 46, 975-979.
23. Lateef, H., Abatan, O. I., Aslam, M. N., Stevens, M. J. and Varani, J. (2005) Topical pretreatment of diabetic rats with all-trans retinoic acid improves healing of subsequently induced abrasion wounds. Diabetes, 54, 855-861.
24. Xu, H., Li, X., Zheng, Q., Huang, Y., Zhao, W., Yao, C., Wu, X. and Huang, Z. (2003) Study on long-term toxicity of recombinant human acidic fibroblast growth factor in rabbits. J. Chin. Pharm. Univ., 34, 46-50.
25. Hehenberger, K., Kratz, G., Hansson, A. and Brismar, K. (1998) Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J. Dermatol. Sci., 16, 144-151.
26. Loots, M. A., Lamme, E. N., Mekkes, J. R., Bos, J. D. and Middelkoop, E. (1999) Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch. Dermatol. Res., 291, 93-99.
27. Root, L. L. and Shipley, G. D. (1991) Human dermal fibroblasts express multiple bFGF and aFGF proteins. In Vitro Cell. Dev. Biol., 27A, 815-822.
28. Root, L. L. and Shipley, G. D. (2000) Normal human fibroblasts produce membrane-bound and soluble isoforms of FGFR-1. Mol. Cell Biol. Res. Commun., 3, 87-97.
29. Bourin, M. C. (1997) Lack of acidic fibroblast growth factor activation by heparan sulfate species from diabetic rat skin. Glycoconj. J., 14, 423-432.
30. Hecquet, C., Morisset, S., Lorans, G., Plouet, J. and Adolphe, M. (1990) Effects of acidic and basic fibroblast growth factors on the proliferation of rabbit corneal cells. Curr. Eye Res., 9, 429-433.
31. Miller, D. L., Ortega, S., Bashayan, O., Basch, R. and Basilico, C. (2000) Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol. Cell Biol., 20, 2260-2268.
32. Eckenstein, F. P., Shipley, G. D. and Nishi, R. (1991) Acidic and basic fibroblast growth factors in the nervous system: distribution and differential alteration of levels after injury of central versus peripheral nerve. J. Neurosci., 11, 412-419.
33. Alberts, G. F., Hsu, D. K., Peifley, K. A. and Winkles, J. A. (1994) Differential regulation of acidic and basic fibroblast growth factor gene expression in fibroblast growth factor-treated rat aortic smooth muscle cells. Circ. Res., 75, 261-267.
34. Fredj-Reygrobellet, D., Plouet, J., Delayre, T., Baudouin, C., Bourret, F. and Lapalus, P. (1987) Effects of aFGF and bFGF on wound healing in rabbit corneas. Curr. Eye Res., 6, 1205-1209.
35. Guzman-Casado, M., Garcia-Mira, M. M., Sanchez-Ruiz, J. M., Gimenez-Gallego, G. and Parody-Morreale, A. (2002) Energetics of heparin binding to human acidic fibroblast growth factor. Int. J. Biol. Macromol., 31, 45-54.
36. Pineda-Lucena, A., Nunez De Castro, I., Lozano, R. M., Munoz-Willery, I., Zazo, M. and Gimenez-Gallego, G. (1994) Effect of low pH and heparin on the structure of acidic fibroblast growth factor. Eur. J. Biochem., 222, 425-431.